சீரம் நிறுவனம் ஆஃப் இந்தியா ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சீரம் நிறுவனம் ஆஃப் இந்தியா ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சீரம் நிறுவனம் ஆஃப் இந்தியா ஸ் Today - Breaking & Trending Today

Covishield maker SII seeks indemnity from liability


Covishield maker SII seeks indemnity from liability
Covishield maker SII seeks indemnity from liability
IANS / Updated: Jun 4, 2021, 09:06 IST
#NEWDELHI Pune-based Serum Institute of India (SII), which manufactures
Covishield, has also sought indemnity from liability, expressing the hope that rules would be the same for everyone, said sources. This comes as the Centre is favourably considering granting indemnity against legal proceedings to foreign vaccine makers Pfizer and Moderna prior to their rollout in India.
“All vaccine makers, whether Indian or foreign, should be granted the same protection,” the Adar Poonawalla-led company has reportedly told the government.
“Not just Serum Institute of India (SII), all the vaccine companies should get indemnity protection against liabilities if foreign companies are granted it,” it further said. It is learnt that Serum is hoping that rules should be same for everyone. The Serum Institute produces Covishie ....

United Kingdom , Oxford Astrazeneca Covishield , Novovax Covovax , Serum Institute , Serum Institute Of India , Adar Poonawalla Led , Drug Controller General , Emergency Use Authorisation , Serum Institute Of India Sii , Russian Sputnikv Covid 19 Vaccine , Foreign Vaccine Pfizer , Emergency Use Authorisation Eua , Astrazeneca Oxford Jab , Anti Covid Vaccines , ஒன்றுபட்டது கிஂக்டம் , சீரம் நிறுவனம் , சீரம் நிறுவனம் ஆஃப் இந்தியா , அடார் பூனாவல்ல வழிநடத்தியது , மருந்து கட்டுப்படுத்தி ஜநரல் , சீரம் நிறுவனம் ஆஃப் இந்தியா ஸ் ,

COVID-19: Serum Institute applies to DCGI to manufacture Sputnik V vaccine in India


COVID-19: Serum Institute applies to DCGI to manufacture Sputnik V vaccine in India
Pune-based Serum Institute has also sought approval for test analysis and examination. Sputnik V is currently being manufactured by Dr Reddy s Lab.
India s Serum Institute seeks approval from DCGI to make Russia s Sputnik V vaccine (Image Source: Reuters)
Share
Updated: Jun 3, 2021, 03:35 PM IST
Pune-based Serum Institute of India (SII), the manufacturer of the Covishield vaccine has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture COVID-19 vaccine Sputnik V in the country, government sources said on Thursday.
The Pune-based vaccine manufacturing firm has also sought approval for test analysis and examination. The SII is currently manufacturing the Covishield doses and the Novavax vaccines. ....

Andhra Pradesh , Stelis Biopharma , Serum Institute Of India , Pune Based Serum Institute , Drug Controller General , Serum Institute , Drugs Controller General , Gland Pharma , Hetero Biopharma , Panacea Biotec , Serum Institute Of India Sii , Covishield Vaccine , Drug Controller General Of India Dcgi , Sputnikv Production In India , Sputnikv Vaccine , Dr Reddy Lab , Covid 19 Vaccine , Vaccine Manufacturing , ஆந்திரா பிரதேஷ் , சீரம் நிறுவனம் ஆஃப் இந்தியா , புனே அடிப்படையிலானது சீரம் நிறுவனம் , மருந்து கட்டுப்படுத்தி ஜநரல் , சீரம் நிறுவனம் , மருந்துகள் கட்டுப்படுத்தி ஜநரல் , சுரப்பி பார்மா , சஞ்சீவி பயோடெக் ,